Clinical Trials Logo

Clinical Trial Summary

Introduction: Williams-Beuren syndrome is a rare genetic disorder caused by a 7q11.23 microdeletion. The phenotype associates vasculopathy (arterial stenosis, hypertension), dimorphism and intellectual disability. Microdeletion includes several genes: ELN encodes for elastin and the haplo-insufficiency (only 1 functional copy) causes vasculopathy.

The primary objective is to quantify plasma and urinary levels of elastin peptides in Williams-Beuren patients and 7q11.23 micro-duplication syndrome patients in order to correlate the levels of these markers with the number of copies of ELN gene (proportional positive relationship "gene copy number - circulating levels of markers) Materials and Methods: This prospective study will be carried out in Lyon at the "Hôpital Femme-Mère-Enfant" for 2 years. 3 groups of patients will be studied: Williams-Beuren patients (N=20), micro-duplication 7q11.23 syndrome patients (N=10) and healthy patients (N=60). Subjects will be followed for 1 day.

Clinical examination (weight, height, blood pressure) and biological sample collection (blood and urine sample) will be carry out for Williams Beuren and micro-duplication 7q11.23 patients group. A large majority of visits will be part of patients' usual care. A large part of patients are systematically seen in consultation once a year. For healthy group, only biological sample collection will be carry out. The PE concentrations will be assessed and compared between the three groups of patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04051086
Study type Interventional
Source Hospices Civils de Lyon
Contact Massimiliano ROSSI, Dr
Phone 04 27 85 55 72
Email Massimiliano.rossi@chu-lyon.fr
Status Not yet recruiting
Phase N/A
Start date October 2019
Completion date October 2021

See also
  Status Clinical Trial Phase
Completed NCT00384540 - Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide Coupling N/A
Recruiting NCT06392347 - Evaluation of Accelerated Sampling Techniques for Vessel Wall Imaging
Enrolling by invitation NCT03537742 - PCSK9 Inhibition After Heart Transplantation Phase 2
Completed NCT05485467 - The Role of CD34 + Stem Cells and Biomarkers in the Development of CAV in HTX Patients
Not yet recruiting NCT05251129 - Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation N/A